武丹丹 博士 药师

教育经历：

2018.09——2024.09 南京大学 药学 博士

2015.09——2018.06 电影天堂 药理学 硕士

2011.09——2015.06 电影天堂 药学 学士

主要研究方向：分子药理学

工作经历:

2024.12——至今 电影天堂 第一附属医院 药师

论文发表情况：

1. Wu Dandan, Zuo Zongchao, Sun Xinning, et al. ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription. Biochem Pharmacol. 2024;224:116206..

2. Wu Dandan, Sun Xining, Li Xin, et al. RRM2 regulates hepatocellular carcinoma progression through activation of TGF-β/Smad signaling and hepatitis B virus transcription. Genes. 2024;15(12):1575.

3. Wu Dandan, Li Berber, Liu Haofeng, et al. In vitro inhibited effect of gap junction composed of Cx43 in the invasion and metastasis of testicular cancer resistanced to cisplatin. Biomedicine & pharmacotherapy. 2018;98:826-833.

4. Wu Dandan, Wu Jianfeng, Liu Haofeng, et al. Role of Pannexin1 channels in the resistance of I-10 testicular cancer cells to cisplatin mediated by ATP/IP3 pathway. Biomedicine & pharmacotherapy. 2017;94:514-522.